Virica Biotech, Inc.
Virica Biotech is dedicated to improving manufacturing productivity and reducing costs in cell and gene therapies and vaccine production by addressing cellular defenses with innovative solutions. They develop Viral Sensitizers (VSE™), a library of small molecule cell enhancers that increase viral yields, quality, and scalability, enabling more accessible and cost-effective therapies.
Industries
Nr. of Employees
small (1-50)
Virica Biotech, Inc.
Products
Small-molecule viral sensitizer reagents
Reagent library of small molecules formulated to transiently antagonize cellular innate immunity during viral vector or vaccine production to increase yield and improve quality attributes.
Small-molecule viral sensitizer reagents
Reagent library of small molecules formulated to transiently antagonize cellular innate immunity during viral vector or vaccine production to increase yield and improve quality attributes.
Services
Supply of small-molecule viral sensitizer reagents
Provision of reagent kits composed of small-molecule enhancers intended to be added to viral production processes to boost yield and quality.
High-throughput screening and discovery services
Rapid screening campaigns using high-throughput virology methods to identify application-specific small-molecule enhancers and candidate combinations.
Process development and integration support
Technical collaboration to integrate enhancers into existing cell lines and production workflows, including DoE-based optimization and bioreactor integration.
Manufacturing economics and cost modeling
Cost and dose-sparing analyses that quantify potential manufacturing savings from yield improvements and reduced vector dose requirements.
Supply of small-molecule viral sensitizer reagents
Provision of reagent kits composed of small-molecule enhancers intended to be added to viral production processes to boost yield and quality.
High-throughput screening and discovery services
Rapid screening campaigns using high-throughput virology methods to identify application-specific small-molecule enhancers and candidate combinations.
Process development and integration support
Technical collaboration to integrate enhancers into existing cell lines and production workflows, including DoE-based optimization and bioreactor integration.
Manufacturing economics and cost modeling
Cost and dose-sparing analyses that quantify potential manufacturing savings from yield improvements and reduced vector dose requirements.
Expertise Areas
- Viral vector manufacturing optimization
- Small-molecule enhancer discovery
- High-throughput virology screening
- Design of Experiments (DoE) for bioprocessing
Key Technologies
- High-throughput screening (HTS) for virology
- Design of Experiments (DoE)
- Cloud-connected bioreactor integration
- Process automation for bioprocessing